www.fdanews.com/articles/71744-endocyte-moves-operations-to-purdue-technology-center
Endocyte Moves Operations to Purdue Technology Center
April 29, 2005
Endocyte recently held an open house to showcase its new, state-of-the-art facilities in the Purdue Research Park's newly expanded flagship incubator. The biotechnology firm, which develops receptor-targeted therapeutics for the treatment of cancer and autoimmune diseases, now holds the anchor tenant position for the Purdue Technology Center's 45,000-square-foot wing, located at 3000 Kent Ave.